Saliva test for Alzheimer’s

Scientists at the University of Alberta have pinpointed three biomarkers for detecting Alzheimer's disease in saliva. The discovery could lead to the development of saliva tests that identify underlying neur...

Bill Gates’ fund targets Alzheimer’s

Bill Gates announced today he is making a personal investment to support the ongoing fight against Alzheimer’s. Writing on his gatesnotes website, he said he would invest $50 million in a Dementia Discovery ...

Biotechs target Alzheimer’s

(USA) A number of leading biotechnology companies are focussing their efforts on conquering Alzheimer's. Last week we reported M3 Biotechnology is developing a drug with the potential to halt the disease....

New drug could ‘halt’ Alzheimer’s

(USA) A potentially game-changing Alzheimer's therapy is to undergo clinical trials in America. Pre-clinical studies carried out by M3 Biotechnology, headquartered in Seattle, of its NDX-1017 drug, showed...